Commission Implementing Regulation (EU) 2022/1480 of 7 September 2022 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bensulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, esfenvalerate, etofenprox, fenoxaprop-P, fenpropidin, fenpyrazamine, fludioxonil, flufenacet, flumetralin, fosthiazate, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, prohexadione, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulphur, tebufenpyrad, tetraconazole, tri-allate, triflusulfuron and tritosulfuron
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act included in a Joint Committee Decision (JCD); entry into force of the Decision is pending Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Legal documents
Commission Implementing Regulation (EU) 2022/1480 of 7 September 2022 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bensulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, esfenvalerate, etofenprox, fenoxaprop-P, fenpropidin, fenpyrazamine, fludioxonil, flufenacet, flumetralin, fosthiazate, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, prohexadione, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulphur, tebufenpyrad, tetraconazole, tri-allate, triflusulfuron and tritosulfuron
Durchführungsverordnung (EU) 2022/1480 der Kommission vom 7. September 2022 zur Änderung der Durchführungsverordnung (EU) Nr. 540/2011 hinsichtlich der Verlängerung der Laufzeit der Genehmigungen für die Wirkstoffe 2-Phenylphenol (einschließlich seiner Salze, z. B. Natriumsalz), 8-Hydroxychinolin, Amidosulfuron, Bensulfuron, Bifenox, Chlormequat, Chlortoluron, Clofentezin, Clomazon, Daminozid, Deltamethrin, Dicamba, Difenoconazol, Diflufenican, Dimethachlor, Esfenvalerat, Etofenprox, Fenoxaprop-P, Fenpropidin, Fenpyrazamin, Fludioxonil, Flufenacet, Flumetralin, Fosthiazat, Lenacil, MCPA, MCPB, Nicosulfuron, Paraffinöle, Paraffinöl, Penconazol, Picloram, Prohexadion, Propaquizafop, Prosulfocarb, Quizalofop-P-ethyl, Quizalofop-P-tefuryl, Natrium-5-nitroguaiacolat, Natrium-o-nitrophenolat, Natrium-p-nitrophenolat, Schwefel, Tebufenpyrad, Tetraconazol, Triallat, Triflusulfuron und Tritosulfuron
History
04.02.2023
Adopted JCD confirmed entry into force date
04.02.2023
Compliance date in the EEA
03.02.2023
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
14.12.2022
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
07.09.2022
Adoption date in the EU
28.09.2022
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.